Literature DB >> 10605579

Cochlear implantation in Thailand.

K Vaewvichit1, P Luangpitakchumpol.   

Abstract

This article evaluates and compares the benefits of a House/3M single channel cochlear implant or a Nucleus 22-channel cochlear implant on speech recognition in Thai-speaking patients. From 1986-1989, four profoundly deaf adults were implanted with the House/3M prosthesis. Since 1994, nine post-lingually deaf adults and three pre-lingually deaf children have been implanted with the Nucleus prosthesis. One case was implanted with the House/3M prosthesis and in the contralateral ear with the Nucleus prosthesis. The post-operative results were determined according to the ability to understand Thai monosyllabic, bisyllabic open-word sets and everyday sentence tests with, and without, lip reading. The scores were then compared in the House/3M users and the Nucleus users and compared between the House/3M cochlear implant and the Nucleus cochlear implant in the same user. The speech recognition scores on monosyllabic and bisyllabic open-word set demonstrated that the Nucleus users perform at a much higher level than the House/3M users. The results of four pre-lingually deaf children will be reported later after a period of auditory and speech rehabilitation.

Entities:  

Mesh:

Year:  1999        PMID: 10605579     DOI: 10.1017/s002221510014438x

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  Multicentre cohort study of cochlear implantation outcomes in Thailand.

Authors:  Patorn Piromchai; Napas Tanamai; Sivaporn Kiatthanabumrung; Suwicha Kaewsiri; Kanthong Thongyai; Viraporn Atchariyasathian; Panida Thanawirattananit; Chitsuda Wacharasindhu; Tulakan Mukkun; Permsarp Isipradit; Kwanchanok Yimtae
Journal:  BMJ Open       Date:  2021-11-29       Impact factor: 2.692

2.  Cochlear implantation in Bahrain: promising results.

Authors:  Ahmed J Jamal; A Rahman M Ghareeb; Omar Y Al-Sharif; Randah R Hamadeh
Journal:  Ann Saudi Med       Date:  2007 Nov-Dec       Impact factor: 1.526

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.